Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 61

1.

Inhaler Errors in the CRITIKAL Study: Type, Frequency, and Association with Asthma Outcomes.

Price DB, Román-Rodríguez M, McQueen RB, Bosnic-Anticevich S, Carter V, Gruffydd-Jones K, Haughney J, Henrichsen S, Hutton C, Infantino A, Lavorini F, Law LM, Lisspers K, Papi A, Ryan D, Ställberg B, van der Molen T, Chrystyn H.

J Allergy Clin Immunol Pract. 2017 Mar 9. pii: S2213-2198(17)30007-7. doi: 10.1016/j.jaip.2017.01.004. [Epub ahead of print]

PMID:
28286157
2.

Cohort profile: the Scottish Research register SHARE. A register of people interested in research participation linked to NHS data sets.

McKinstry B, Sullivan FM, Vasishta S, Armstrong R, Hanley J, Haughney J, Philip S, Smith BH, Wood A, Palmer CN.

BMJ Open. 2017 Feb 1;7(2):e013351. doi: 10.1136/bmjopen-2016-013351.

3.

First maintenance therapy for COPD in the UK between 2009 and 2012: a retrospective database analysis.

Price D, Miravitlles M, Pavord I, Thomas M, Wedzicha J, Haughney J, Bichel K, West D.

NPJ Prim Care Respir Med. 2016 Nov 3;26:16061. doi: 10.1038/npjpcrm.2016.61.

4.

Core requirements for successful data linkage: an example of a triangulation method.

Hopf YM, Francis J, Helms PJ, Haughney J, Bond C.

BMJ Open. 2016 Oct 21;6(10):e011879. doi: 10.1136/bmjopen-2016-011879.

5.

Cost versus utility of aclidinium bromide 400 µg plus formoterol fumarate dihydrate 12 µg compared to aclidinium bromide 400 µg alone in the management of moderate-to-severe COPD.

Ramos M, Haughney J, Henry N, Lindner L, Lamotte M.

Clinicoecon Outcomes Res. 2016 Sep 12;8:445-56. doi: 10.2147/CEOR.S107121. eCollection 2016.

6.

Metabolic Effects Associated with ICS in Patients with COPD and Comorbid Type 2 Diabetes: A Historical Matched Cohort Study.

Price DB, Russell R, Mares R, Burden A, Skinner D, Mikkelsen H, Ding C, Brice R, Chavannes NH, Kocks JW, Stephens JW, Haughney J.

PLoS One. 2016 Sep 22;11(9):e0162903. doi: 10.1371/journal.pone.0162903. eCollection 2016.

7.

Assessing Asthma Symptoms in Adolescents and Adults: Qualitative Research Supporting Development of the Asthma Daily Symptom Diary.

Gater A, Nelsen L, Fleming S, Lundy JJ, Bonner N, Hall R, Marshall C, Staunton H, Krishnan JA, Stoloff S, Schatz M, Haughney J; Patient-Reported Outcome Consortium’s Asthma Working Group.

Value Health. 2016 Jun;19(4):440-50. doi: 10.1016/j.jval.2016.01.007. Epub 2016 Mar 30.

8.

Characteristics of patients making serious inhaler errors with a dry powder inhaler and association with asthma-related events in a primary care setting.

Westerik JA, Carter V, Chrystyn H, Burden A, Thompson SL, Ryan D, Gruffydd-Jones K, Haughney J, Roche N, Lavorini F, Papi A, Infantino A, Roman-Rodriguez M, Bosnic-Anticevich S, Lisspers K, Ställberg B, Henrichsen SH, van der Molen T, Hutton C, Price DB.

J Asthma. 2016;53(3):321-9. doi: 10.3109/02770903.2015.1099160. Epub 2016 Jan 26.

9.

Comparison of serious inhaler technique errors made by device-naïve patients using three different dry powder inhalers: a randomised, crossover, open-label study.

Chrystyn H, Price DB, Molimard M, Haughney J, Bosnic-Anticevich S, Lavorini F, Efthimiou J, Shan D, Sims E, Burden A, Hutton C, Roche N.

BMC Pulm Med. 2016 Jan 14;16:12. doi: 10.1186/s12890-016-0169-5.

10.

Assessing the Cost-Effectiveness of using Aclidinium Bromide 400 µG /Formoterol Fumarate Dihydrate 12 µG Compared to Aclidinium Bromide 400 µG in the Management of Moderate to Severe Chronic Obstructive Pulmonary Disease.

Ramos M, Haughney J, Henry N, Lindner L, Lamotte M.

Value Health. 2015 Nov;18(7):A340. doi: 10.1016/j.jval.2015.09.139. Epub 2015 Oct 20. No abstract available.

11.

Linking NHS data for pediatric pharmacovigilance: Results of a Delphi survey.

Hopf YM, Francis J, Helms PJ, Haughney J, Bond C.

Res Social Adm Pharm. 2016 Mar-Apr;12(2):267-80. doi: 10.1016/j.sapharm.2015.06.006. Epub 2015 Jul 2.

12.

Use of low-dose oral theophylline as an adjunct to inhaled corticosteroids in preventing exacerbations of chronic obstructive pulmonary disease: study protocol for a randomised controlled trial.

Devereux G, Cotton S, Barnes P, Briggs A, Burns G, Chaudhuri R, Chrystyn H, Davies L, De Soyza A, Fielding S, Gompertz S, Haughney J, Lee AJ, McCormack K, McPherson G, Morice A, Norrie J, Sullivan A, Wilson A, Price D.

Trials. 2015 Jun 10;16:267. doi: 10.1186/s13063-015-0782-2.

13.

Preference, satisfaction and critical errors with Genuair and Breezhaler inhalers in patients with COPD: a randomised, cross-over, multicentre study.

Pascual S, Feimer J, De Soyza A, Sauleda Roig J, Haughney J, Padullés L, Seoane B, Rekeda L, Ribera A, Chrystyn H.

NPJ Prim Care Respir Med. 2015 Apr 30;25:15018. doi: 10.1038/npjpcrm.2015.18.

14.

Serum periostin in smokers and never smokers with asthma.

Thomson NC, Chaudhuri R, Spears M, Haughney J, McSharry C.

Respir Med. 2015 Jun;109(6):708-15. doi: 10.1016/j.rmed.2015.03.009. Epub 2015 Apr 3.

15.

Characterisation of the frequent exacerbator phenotype in COPD patients in a large UK primary care population.

McGarvey L, Lee AJ, Roberts J, Gruffydd-Jones K, McKnight E, Haughney J.

Respir Med. 2015 Feb;109(2):228-37. doi: 10.1016/j.rmed.2014.12.006. Epub 2014 Dec 30.

16.

'The more you link, the more you risk …' - a focus group study exploring views about data linkage for pharmacovigilance.

Hopf YM, Bond C, Francis J, Haughney J, Helms PJ.

Br J Clin Pharmacol. 2014 Nov;78(5):1143-50. doi: 10.1111/bcp.12445.

17.

Case-finding of chronic obstructive pulmonary disease with questionnaire, peak flow measurements and spirometry: a cross-sectional study.

Mahboub B, Alzaabi A, Soriano JB, Salameh L, Mutairi YA, Yusufali AA, Alsheikh-ali A, Almahmeed W, Haughney J.

BMC Res Notes. 2014 Apr 16;7:241. doi: 10.1186/1756-0500-7-241.

18.

Guidance on handheld inhalers in asthma and COPD guidelines.

Dekhuijzen PN, Bjermer L, Lavorini F, Ninane V, Molimard M, Haughney J.

Respir Med. 2014 May;108(5):694-700. doi: 10.1016/j.rmed.2014.02.013. Epub 2014 Mar 1. Review.

19.

Linked health data for pharmacovigilance in children: perceived legal and ethical issues for stakeholders and data guardians.

Hopf YM, Bond CB, Francis JJ, Haughney J, Helms PJ.

BMJ Open. 2014 Feb 12;4(2):e003875. doi: 10.1136/bmjopen-2013-003875.

20.

Switching from branded to generic inhaled medications: potential impact on asthma and COPD.

Lavorini F, Ninane V, Haughney J, Bjermer L, Molimard M, Dekhuijzen RP.

Expert Opin Drug Deliv. 2013 Dec;10(12):1597-602. doi: 10.1517/17425247.2013.852182. Epub 2013 Nov 14.

PMID:
24224777

Supplemental Content

Loading ...
Support Center